OSUR files FDA applications seeking approval for two at-home STI tests, advancing decentralized diagnostics; shares gain 3.8% as it targets long-term growth.
OraSure Technologies, Inc. (NASDAQ: OSUR) (“OraSure” and “OTI”), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that it submitted two separate ...
Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last year. There are currently no approved vaccines to protect against chlamydia – ...
Detailed price information for Orasure Tech Inc (OSUR-Q) from The Globe and Mail including charting and trades.
The cornerstone of sexually transmitted infection (STI) control is early diagnosis and treatment, including the treatment of sexual partners. These measures prevent complications in the treated ...
Technologies submitted two separate applications at the end of 2025 to the U.S. Food and Drug Administration for clearance of its ...
PCR-Machines are based on Polymerase Chain Reaction (PCR) and produce copies of genes exponentially. The PCR cycling reactions are carried out in an automated thermocycler, which is capable of heating ...
Young people aged 15 to 24 are most likely to get chlamydia. Chlamydia can be spread through unprotected sex. Untreated chlamydia may cause serious health problems, especially for people with uteruses ...
Department of Medicine, Klinikum Steglitz, Free University of Berlin, Germany. OBJECTIVE--To examine whether reactive arthritis (ReA) known to occur after a urogenital infection with Chlamydia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback